Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

P1040 TENOFOVIR FOR THE PROPHYLAXIS OF HBV REACTIVATION IN ANTI-HBC-POSITIVE PATIENTS WITH HEMATOLOGIC MALIGNANCIES TREATED WITH RITUXIMAB: PRELIMINARY RESULTS OF A RANDOMIZED STUDY (PREBLIN STUDY)

P1040 TENOFOVIR FOR THE PROPHYLAXIS OF HBV REACTIVATION IN ANTI-HBC-POSITIVE PATIENTS WITH... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Hepatology CrossRef

P1040 TENOFOVIR FOR THE PROPHYLAXIS OF HBV REACTIVATION IN ANTI-HBC-POSITIVE PATIENTS WITH HEMATOLOGIC MALIGNANCIES TREATED WITH RITUXIMAB: PRELIMINARY RESULTS OF A RANDOMIZED STUDY (PREBLIN STUDY)

Loading next page...
 
/lp/crossref/p1040-tenofovir-for-the-prophylaxis-of-hbv-reactivation-in-anti-hbc-5UGatI5OcQ

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
CrossRef
ISSN
0168-8278
DOI
10.1016/s0168-8278(14)61200-9
Publisher site
See Article on Publisher Site

Abstract

Journal

Journal of HepatologyCrossRef

Published: Apr 1, 2014

There are no references for this article.